Shattuck Labs, Inc., a clinical-stage biotechnology company, engages in the development of antibodies for the treatment of inflammatory and immune-mediated diseases in the United States. The company develops SL-325, a death receptor 3 block...
Leadership
Taylor H. Schreiber M.D., Ph.D.Founder
Co-Founder, CEO & Director
Andrew R. Neill M.B.A.
Chief Financial Officer
Arunthathy Nirmalini Pandite M.B.A., M.D.
Chief Medical Officer
Brad Huckabee
Vice President of Accounting & SEC reporting
Abhinav A. Shukla Ph.D.
Chief Technical Officer
Stephen Stout J.D., Ph.D.
General Counsel, Corporate Secretary and Chief Ethics & Compliance Officer
